DMA Edu

No Result

View All Result

No Result

View All Result

No Result

View All Result

Home News

Rystiggo Approved By The Fda For Generalized Myasthenia Gravis

First FDA-approved treatment for adults with both anti-AChR and anti-MuSK antibody-positive generalized myasthenia gravis

by Dr.P.Harinath

August 23, 2023

in News, Daily, World

Rystiggo Approved By The Fda For Generalized Myasthenia Gravis

FDA approves nirsevimab-alip to prevent severe RSV in babies and toddlers

Is vision loss a modifiable risk factor for developing dementia?

Dr.P.Harinath

Next Post

Is vision loss a modifiable risk factor for developing dementia?

Is vision loss a modifiable risk factor for developing dementia?

www.dma-study.com

Follow Us

© 2022 DMAEdu

No Result

View All Result

© 2022 DMAEdu